As more women turn to genetic testing for breast cancer, understanding risk is key – Washington Post


Washington Post

As more women turn to genetic testing for breast cancer, understanding risk is key
Washington Post
The Food and Drug Administration not long ago announced its authorization that permits genetics testing company 23andMe to market a test for gene mutations associated with risk of breast and ovarian cancer. In response, 23andMe CEO Anne Wojcicki …
Is 23andMe's Test For Breast Cancer Gene Mutation Good For Jewish Women?Forward

all 4 news articles »

Leave a Reply

Your email address will not be published.

Back to Top